Mehnaz Shafi

Appearances

CARDIAC SAFETY AND CLINICAL EFFICACY OF DOMPERIDONE USE IN GASTROPARESIS USING AN FDA APPROVED IND PROTOCOL : A PROSPECTIVE 11-YEARS STUDY
Date
May 21, 2024
BACKGROUND:Domperidone, a D2 receptor antagonist, has been in clinical use in Europe and Asia since 1974. This drug is not FDA approved in USA. There are concerns about its cardiac toxicity, including QT prolongation, Torsade’s de pointes or sudden death…
Presenter
Irfan Yusuf
Speakers
Shamim Ejaz
David Richards
Leah Vinluan
Raza Bokhari
Catherine Rytting
Mehnaz Shafi